摘要
胸腺素α1是机体内的一种免疫活性肽,目前已用于乙型、丙型肝炎及恶性肿瘤、免疫缺陷等疾病的研究和临床治疗中。其作用机制尚不十分清楚,一般被认为具有生物反应调节物的功能。现对胸腺素α1的分布、作用机制及临床应用进行综述,并总结胸腺素α1在生物制备上的进展。
Thymosin α1 （Tα1） was an immune active peptide in vivo. It was used in the treatment of hepatitis B, hepatitis C, tumors and immune-deficiency syndrome. It was generally considered as an important biological response modifier, though the mechanisms of Tα1 was still not well mastered. Here, we reviewed the distribution, mechanism model of functions, and clinical application of Tα1, and summarized its recent development in biosynthesis.
出处
《细胞生物学杂志》
CSCD
2005年第6期621-624,共4页
Chinese Journal of Cell Biology
关键词
胸腺素Α1
生物反应调节物
临床应用
thymosin α1
biological response modifier
clinical application
